Skip to main content
Median Diagnostics Inc. logo

Median Diagnostics Inc. — Investor Relations & Filings

Ticker · 233250 ISIN · KR7233250000 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2020-10-12 Report Publication Anno…
Country KR South Korea
Listing KO 233250

About Median Diagnostics Inc.

https://www.mediandiagnostics.com/en

Median Diagnostics Inc. specializes in the development, manufacturing, and supply of in-vitro diagnostic products for animal diseases. The company provides a comprehensive portfolio of diagnostic solutions, including ELISA and PCR kits, rapid tests, and standard reagents. It also produces essential raw materials such as monoclonal antibodies and antigens. A primary focus is on offering 'Total Diagnostic Systems' for high-consequence animal diseases, including African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), High Pathogenicity Avian Influenza (HPAI), Porcine Epidemic Diarrhea (PED), and Bovine Viral Diarrhea (BVD). The company also supplies raw materials for human disease diagnostic applications.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, purpose, and agenda for the event. Since this is an announcement of an upcoming presentation rather than the presentation slides themselves, and it serves as a regulatory notification of an event, it falls under the category of a general regulatory filing or announcement regarding corporate activities.
2020-10-12 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific quantity, price, and date of treasury shares disposed of by the company (Median Diagnostics). This falls directly under the category of a company reporting the sale or disposal of its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2020-04-24 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This filing specifically details the company's plan to sell or transfer its own shares, which falls under the category of 'Transaction in Own Shares' (POS).
2020-04-23 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Median Diagnostics' (주식회사 메디안디노스틱) for the fiscal year 2019. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a full financial reporting document, not an announcement or a summary, and therefore fits the 'Audit Report / Information' category. FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed, including financial statement approval, auditor appointment, and director/auditor remuneration limits. It explicitly lists the voting outcomes for each agenda item. This fits the definition of a Declaration of Voting Results (DVA).
2020-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 99% confidence The document is a formal filing titled '감사보고서 제출' (Submission of Audit Report) from Median Diagnostics. It provides a summary of the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, revenue, profit), and details about the external auditor. While it contains financial data, it is a regulatory disclosure announcing the receipt and submission of the audit report to the exchange, rather than the full annual report or a standalone audit document. Given the structure and content, it fits the 'Audit Report / Information' category as it specifically reports on the audit outcome and financial summary. FY 2019
2020-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.